NCT04879329 2026-04-21A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2Seagen Inc.Phase 2 Recruiting372 enrolled
NCT05911295 2026-04-20Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2Seagen Inc.Phase 3 Active not recruiting412 enrolled